Anthony S. Basile, E. Anthony Jones, Peter Widler, Hans U. Fisch, Thomas Schläepfer, Jürg Reichen, Peter Schoch – 1 August 1994

Frank J. Farrell, Marie Nguyen, Susan Woodley, Joanne C. Imperial, Richard Garcia‐Kennedy, Kevin Man, Carlos O. Esquivel, Emmet B. Keeffe – 1 August 1994 – Recent preliminary reports suggest a poor outcome of orthotopic liver transplantation for patients with hemochromatosis. We analyzed an institutional experience with orthotopic liver transplantation for hemochromatosis, focusing on factors contributing to increased morbidity and mortality. Between March 1988 and October 1992, nine of 249 adults (3.6%) undergoing orthotopic liver transplantation had hemochromatosis.

Wolf‐Bernhard Offensperger, Silke Offensperger, Barbara Stoll, Wolfgang Gerok, Dieter Häussinger – 1 July 1994 – In cultured hepatocytes from in vivo duck hepatitis B virus‐infected ducks the effect of medium osmolarity on viral replication was studied. A 10‐day exposure to hypotonic media (277 mOsm/L due to removal of 26 mmol/L NaCl) lowered the duck hepatitis B virus DNA content of cells and of the medium by about 50%, whereas hyperosmotic exposure (421 mOsm/L by addition of 46 mmol/L NaCl) increased it about four‐fold compared with normotonic standard incubation medium (329 mOsm/L).

Arun J. Sanyal, Arthur M. Freedman, Mitchell L. Shiffman, Preston P. Purdum, Velimir A. Luketic, Andrea K. Cheatham – 1 July 1994 – Portosystemic encephalopathy is a common complication of surgical portacaval shunts. Recently, transjugular intrahepatic portosystemic shunts have been proposed to produce portal decompression in a manner analogous to a side‐to‐side portacaval shunt, but with less morbidity. The incidence and clinical spectrum of portosystemic encephalopathy after transjugular intrahepatic portosystemic shunts, however, had not been previously prospectively defined.

Mathew E. Brunson, Gary L. Davis, Johnson Y. N. Lau, Juan C. Scornik, Richard C. Howard, William W. Pfaff – 1 July 1994

Nancy L. Ascher, John R. Lake, Jean Emond, John Roberts – 1 July 1994 – Since the introduction of techniques to reliably identify antibody to the hepatitis C virus and quantitation of hepatitis C virus, there has been an increasing interest in the behavior of chronic hepatitis C infection with liver transplantation. Ninety‐seven patients with chronic active hepatitis C and fifty‐nine patients with cryptogenic cirrhosis underwent 100 and 62 liver transplantation procedures, respectively, at a single institution.

Dena M. Selby, J. Thomas Stocker, Myron A. Waclawiw, Charles L. Hitchcock, Kamal G. Ishak – 1 July 1994 – Clinical and morphological findings in 91 patients with infantile hemangioendothelioma of the liver are reported. The study comprised 56 girls and 35 boys ranging in age from premature infant to 3 yr; one outlier patient was 18 yr old. Most patients with infantile hemangioendothelioma (87%) were first seen before the age of 6 mo. Congestive heart failure was evident in 15%. Skin hemangiomas were noted in 11%. Anemia, hyperbilirubinemia and increased AST level were present.

Marc W. Fariss, Sharon A. Johnsen, Lloyd P. Walton, Virgil R. Mumaw, Sidhartha D. Ray – 1 July 1994 – Tacrine (tetrahydroaminoacridine) is currently the only drug approved for the treatment of Alzheimer's disease. Unfortunately, tetrahydroaminoacridine therapy is often limited by this drug's propensity to induce reversible hepatotoxicity.

Giampaolo Bianchi, Giulio Marchesini, Marco Zoli, Elisabetta Bugianesi, Andrea Fabbri, Emilio Pisi – 1 July 1994 – Alterations in carbohydrate metabolism are frequently observed in cirrhosis, and approximately 15% to 30% of patients have overt diabetes. In a retrospective and prospective study in cirrhosis, we analyzed the prognostic significance of diabetes, which was defined as the presence of hyperglycemia and overt glycosuria that in most cases required dietary restrictions or active treatment.

Margaret J. Stalker, Trudy E. Kocal, Bette Anne Quinn, Sonya G. Gordon, M. Anthony Hayes – 1 July 1994 – We followed the expression of several glutathione S‐transferase subunits in altered foci, liver neoplasms and metastases produced in male Fischer 344 rats by a modified Solt‐Farber protocol, to determine whether components of the resistant phenotype are lost during neoplastic progression.